Physician
Livania Zavala-Spinetti MD PA
Livania Zavala-Spinetti MD PA was paid $4.24M by Medicaid between Nov 2018 and Dec 2024, across 79 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 30% of everything it billed.
33Billing provider infoLIVANIA ZAVALA-SPINETTI MD PA
EDINBURG, TX 78539
EDINBURG, TX 78539
33aNPI1205017084assigned 11/20/2007
33bProvider typePediatrics Physician
28Total paid$4.24M
24GClaims184,407
24DCodes billed79
24AFirst – last monthNov 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Texas
Rank by total paid#104 of 1,136
Median peer was paid$329K
This provider vs. median13×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 182 | $5K | |
| 2019 | 29 | $686.44 | |
| 2020 | 5,335 | $111K | |
| 2021 | 37,938 | $831K | |
| 2022 | 49,831 | $1.17M | |
| 2023 | 45,668 | $1.07M | |
| 2024incomplete | 45,424 | $1.05M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 30% | 36,688 | 28,323 | $1.28M |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 15% | 14,891 | 13,245 | $616K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13% | 13,206 | 11,210 | $569K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.7% | 3,353 | 3,271 | $243K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 5.5% | 9,543 | 8,732 | $232K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5.0% | 3,155 | 2,928 | $211K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.6% | 2,659 | 2,580 | $196K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 4.5% | 14,630 | 13,267 | $192K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 3.7% | 14,769 | 7,129 | $156K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.6% | 1,940 | 1,868 | $152K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.5% | 5,801 | 3,935 | $66K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.3% | 8,602 | 7,748 | $53K |
67 more codes
| 99203 | Doctor's office visit, new patient (routine) | <1% | 618 | $33K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 3,671 | $29K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 2,844 | $25K |
| 92551 | <1% | 5,019 | $24K | |
| 99381 | <1% | 307 | $22K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 193 | $17K |
| 87807 | <1% | 1,421 | $15K | |
| 87428 | <1% | 194 | $12K | |
| 0071A | <1% | 324 | $11K | |
| 99050 | <1% | 1,551 | $11K | |
| 99051 | <1% | 2,297 | $8K | |
| 0072A | <1% | 217 | $8K | |
| 90461 | <1% | 1,832 | $7K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 281 | $7K |
| 99383 | <1% | 92 | $7K | |
| 0001A | <1% | 161 | $6K | |
| 81002 | <1% | 2,016 | $6K | |
| 0002A | <1% | 123 | $5K | |
| 99429 | <1% | 144 | $4K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 383 | $3K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 3,961 | $3K |
| 93975 | <1% | 13 | $2K | |
| 90619 | <1% | 362 | $2K | |
| 96160 | <1% | 925 | $1K | |
| 99000 | <1% | 111 | $1K | |
| 86580 | <1% | 201 | $1K | |
| 99382 | <1% | 12 | $1K | |
| 90671 | <1% | 773 | $831.96 | |
| 0003A | <1% | 25 | $800.00 | |
| 82274 | <1% | 64 | $784.29 | |
| 80305 | <1% | 54 | $571.32 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 237 | $449.26 |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 46 | $398.82 |
| 92552 | <1% | 35 | $395.70 | |
| 86308 | <1% | 85 | $343.65 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,303 | $274.25 |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 26 | $180.32 |
| 90734 | <1% | 177 | $150.23 | |
| 90686 | <1% | 1,309 | $56.08 | |
| 84030 | <1% | 105 | $46.34 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 31 | $1.23 |
| 83655 | <1% | 58 | $0.26 | |
| 85018 | <1% | 26 | $0.12 | |
| 90696 | 0% | 234 | $0.00 | |
| 90744 | 0% | 1,042 | $0.00 | |
| 91307 | 0% | 615 | $0.00 | |
| 90688 | 0% | 51 | $0.00 | |
| 90698 | 0% | 1,819 | $0.00 | |
| 90680 | 0% | 1,621 | $0.00 | |
| 90651 | 0% | 401 | $0.00 | |
| 90716 | 0% | 321 | $0.00 | |
| 36416 | 0% | 573 | $0.00 | |
| 90656 | 0% | 186 | $0.00 | |
| 90710 | 0% | 620 | $0.00 | |
| 90707 | 0% | 363 | $0.00 | |
| 99177 | 0% | 4,591 | $0.00 | |
| 91300 | 0% | 354 | $0.00 | |
| 90633 | 0% | 1,277 | $0.00 | |
| 90648 | 0% | 246 | $0.00 | |
| 90685 | 0% | 46 | $0.00 | |
| 90670 | 0% | 1,674 | $0.00 | |
| 90700 | 0% | 269 | $0.00 | |
| 90715 | 0% | 222 | $0.00 | |
| 90621 | 0% | 12 | $0.00 | |
| 99173 | 0% | 339 | $0.00 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 0% | 4,647 | $0.00 |
| 99072 | 0% | 20 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialZAVALA-SPINETTI, LIVANIA (OWNER)